Skip to main content
European Commission logo
italiano italiano
CORDIS - Risultati della ricerca dell’UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Programmable nucleic acid toolkits for cell-free diagnostics and genetically encoded biosensing

Descrizione del progetto

Nanotecnologia a base di acido nucleico per la creazione di strumenti diagnostici decentrati privi di cellule

La complessità biologica dei tumori e la diversità dei biomarcatori diagnostici richiedono lo sviluppo di strumenti analitici innovativi per il rilevamento di molteplici obiettivi in modo economico, specifico e sensibile tali da consentire il monitoraggio in tempo reale della progressione della malattia e degli effetti terapeutici. L’obiettivo del progetto PRO-TOOLKITS, finanziato dall’UE, consiste nell’introdurre kit diagnostici innovativi decentrati privi di cellule e strumenti di biorilevamento geneticamente manipolati. I ricercatori svilupperanno moduli di acido nucleico programmabili progettati razionalmente che rispondono a una vasta gamma di marcatori molecolari e di stimoli ambientali. Il lavoro del progetto condurrà a delle scoperte significative nei campi della diagnostica in vitro, del biorilevamento e della biologia sintetica.

Obiettivo

WHY: The biological complexity of tumours and the large diversity of diagnostic biomarkers call for the development of innovative analytical tools that can detect multiple targets in a sensitive, specific and low-cost way and allow real-time monitoring of disease pathways and therapeutic effects. To provide such transformative tools creative thinking, innovative approach and the exploration of new research avenues that span different disciplines is necessary.

WHAT: The goal of the PRO-TOOLKITS project is to address this need by developing innovative cell-free point of care diagnostic kits and genetically encodable biosensing tools.

HOW: I oriented my independent career as a P.I. towards the design and development of synthetic nucleic acid-based nanodevices and nanomachines. With the help of an ERC Starting Grant I made ground-breaking contributions in the field of nucleic acid Nanotechnology. Motivated by these advancements I propose to challenge my know-how and expertise to explore new research avenues that will open exciting possibilities in biosensing applications. The key, ground-breaking IDEA underlying this project is to take advantage of my expertise and harness the advantageous features of RNA synthetic modules that can translate the expression of proteins in controlled in-vitro cell-free systems and can be also genetically encoded in living organisms and function inside the cells. I will develop rationally designed programmable nucleic acid modules that respond to a wide range of molecular markers and environmental stimuli through innovative nature-inspired mechanisms and that can be orthogonally wired to provide cell-free diagnostic kits and genetically encoded live-cell biosensing tools. The project will provide transformative approaches, methods and tools that will represent a genuine break-through in the fields of in-vitro diagnostics, biosensing and synthetic biology.

Meccanismo di finanziamento

ERC-COG - Consolidator Grant

Istituzione ospitante

UNIVERSITA DEGLI STUDI DI ROMA TOR VERGATA
Contribution nette de l'UE
€ 1 999 375,00
Indirizzo
VIA CRACOVIA 50
00133 Roma
Italia

Mostra sulla mappa

Regione
Centro (IT) Lazio Roma
Tipo di attività
Higher or Secondary Education Establishments
Collegamenti
Costo totale
€ 1 999 375,00

Beneficiari (1)